Your browser doesn't support javascript.
loading
An Oncogenic Alteration Creates a Microenvironment that Promotes Tumor Progression by Conferring a Metabolic Advantage to Regulatory T Cells.
Kumagai, Shogo; Togashi, Yosuke; Sakai, Chika; Kawazoe, Akihito; Kawazu, Masahito; Ueno, Toshihide; Sato, Eiichi; Kuwata, Takeshi; Kinoshita, Takahiro; Yamamoto, Masami; Nomura, Sachiyo; Tsukamoto, Tetsuya; Mano, Hiroyuki; Shitara, Kohei; Nishikawa, Hiroyoshi.
Afiliación
  • Kumagai S; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo/Chiba, Japan; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Togashi Y; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo/Chiba, Japan. Electronic address: ytogashi1584@gmail.com.
  • Sakai C; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo/Chiba, Japan.
  • Kawazoe A; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Kawazu M; Division of Cellular Signaling, Group for Cancer Development and Progression, National Cancer Center Research Institute, Tokyo, Japan.
  • Ueno T; Division of Cellular Signaling, Group for Cancer Development and Progression, National Cancer Center Research Institute, Tokyo, Japan.
  • Sato E; Department of Pathology, Institute of Medical Science, Tokyo Medical University, Tokyo, Japan.
  • Kuwata T; Department of Pathology and Clinical Laboratories, National Cancer Center Hospital East, Chiba, Japan.
  • Kinoshita T; Department of Gastric Surgery, National Cancer Center Hospital East, Chiba, Japan.
  • Yamamoto M; Division of Physiological Pathology, Department of Applied Science, School of Veterinary Nursing and Technology, Nippon Veterinary and Life Science University, Tokyo, Japan.
  • Nomura S; Department of Gastrointestinal Surgery, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan.
  • Tsukamoto T; Department of Pathology, Graduate School of Medicine, Fujita Health University, Aichi, Japan.
  • Mano H; Division of Cellular Signaling, Group for Cancer Development and Progression, National Cancer Center Research Institute, Tokyo, Japan.
  • Shitara K; Department of Gastrointestinal Oncology, National Cancer Center Hospital East, Chiba, Japan.
  • Nishikawa H; Division of Cancer Immunology, Research Institute/Exploratory Oncology Research and Clinical Trial Center (EPOC), National Cancer Center, Tokyo/Chiba, Japan; Department of Immunology, Nagoya University Graduate School of Medicine, Nagoya, Japan. Electronic address: hnishika@ncc.go.jp.
Immunity ; 53(1): 187-203.e8, 2020 07 14.
Article en En | MEDLINE | ID: mdl-32640259
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Linfocitos T Reguladores / Linfocitos T CD8-positivos / Proteína de Unión al GTP rhoA / Inhibidores de Puntos de Control Inmunológico Límite: Animals / Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Linfocitos T Reguladores / Linfocitos T CD8-positivos / Proteína de Unión al GTP rhoA / Inhibidores de Puntos de Control Inmunológico Límite: Animals / Humans Idioma: En Revista: Immunity Asunto de la revista: ALERGIA E IMUNOLOGIA Año: 2020 Tipo del documento: Article País de afiliación: Japón